<div class="mw-parser-output"><table class="box-Lead_too_long plainlinks metadata ambox ambox-style ambox-lead_too_long" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/40px-Edit-clear.svg.png" decoding="async" width="40" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/60px-Edit-clear.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/80px-Edit-clear.svg.png 2x" data-file-width="48" data-file-height="48" /></div></td><td class="mbox-text"><div class="mbox-text-span">This article's <b><a href="/wiki/Wikipedia:Manual_of_Style/Lead_section" title="Wikipedia:Manual of Style/Lead section">lead section</a> may be too long for the length of the article</b>.<span class="hide-when-compact"> Please help by moving some material from it into the body of the article. Please read the <a href="/wiki/Wikipedia:Manual_of_Style/Layout" title="Wikipedia:Manual of Style/Layout">layout guide</a> and <a href="/wiki/Wikipedia:Manual_of_Style/Lead_section#Length" title="Wikipedia:Manual of Style/Lead section">lead section guidelines</a> to ensure the section will still be inclusive of all essential details. Please discuss this issue on the article's <a href="/wiki/Talk:Placebo-controlled_study" title="Talk:Placebo-controlled study">talk page</a>.</span>  <span class="date-container"><i>(<span class="date">December 2020</span>)</i></span></div></td></tr></tbody></table>
<div class="thumb tright"><div class="thumbinner" style="width:252px;"><a href="/wiki/File:Cebocap.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Cebocap.jpg/250px-Cebocap.jpg" decoding="async" width="250" height="189" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Cebocap.jpg/375px-Cebocap.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/1/1c/Cebocap.jpg 2x" data-file-width="500" data-file-height="377" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Cebocap.jpg" class="internal" title="Enlarge"></a></div>Prescription placebos used in research and practice.</div></div></div>
<p><b>Placebo-controlled studies</b> are a way of testing a medical therapy in which, in addition to a group of subjects that receives the treatment to be evaluated, a separate <a href="/wiki/Scientific_control" title="Scientific control">control</a> group receives a sham "<a href="/wiki/Placebo" title="Placebo">placebo</a>" treatment which is specifically designed to have no real effect. Placebos are most commonly used in <a href="/wiki/Blind_experiment" class="mw-redirect" title="Blind experiment">blinded</a> trials, where subjects do not know whether they are receiving real or placebo treatment. Often, there is also a further "natural history" group that does not receive any treatment at all.
</p><p>The purpose of the placebo group is to account for the <a href="/wiki/Placebo_effect" class="mw-redirect" title="Placebo effect">placebo effect</a>, that is, effects from treatment that do not depend on the treatment itself. Such factors include knowing one is receiving a treatment, attention from health care professionals, and the expectations of a treatment's effectiveness by those running the research study. Without a placebo group to compare against, it is not possible to know whether the treatment itself had any effect.
</p><p>Patients frequently show improvement even when given a sham or "fake" treatment. Such intentionally inert <a href="/wiki/Placebo" title="Placebo">placebo</a> treatments can take many forms, such as a pill containing only sugar, a surgery where nothing efficacious is actually done (just an incision and sometimes some minor touching or handling of the underlying structures), or a medical device (such as an <a href="/wiki/Medical_ultrasonography" class="mw-redirect" title="Medical ultrasonography">ultrasound machine</a>) that is not actually turned on. Also, due to the body's natural healing ability and statistical effects such as <a href="/wiki/Regression_to_the_mean" class="mw-redirect" title="Regression to the mean">regression to the mean</a>, many patients will get better even when given no treatment at all. Thus, the relevant question when assessing a treatment is not "does the treatment work?" but "does the treatment work better than a placebo treatment, or no treatment at all?" As one early <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trial</a> researcher wrote, "the first object of a therapeutic trial is to discover whether the patients who receive the treatment under investigation are cured more rapidly, more completely or more frequently, than they would have been without it."<sup id="cite_ref-1" class="reference"><a href="#cite_note-1">&#91;1&#93;</a></sup><sup>p.195</sup> More broadly, the aim of a <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trial</a> is to determine what treatments, delivered in what circumstances, to which patients, in what conditions, are the most effective.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup><sup id="cite_ref-3" class="reference"><a href="#cite_note-3">&#91;3&#93;</a></sup>
</p><p>Therefore, the use of placebos is a standard <a href="/wiki/Scientific_control" title="Scientific control">control</a> component of most <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trials</a>, which attempt to make some sort of <a href="/wiki/Quantitative_property" class="mw-redirect" title="Quantitative property">quantitative</a> assessment of the efficacy of medicinal drugs or treatments. Such a test or clinical trial is called a <i>placebo-controlled</i> study, and its control is of the <a href="/wiki/Scientific_control#Negative" title="Scientific control">negative</a> type. A study whose control is a previously tested treatment, rather than no treatment, is called a <i>positive-control</i> study, because its control is of the <a href="/wiki/Scientific_control#Positive" title="Scientific control">positive</a> type. Government regulatory agencies approve new drugs only after tests establish not only that patients respond to them, but also that their effect is greater than that of a placebo (by way of affecting more patients, by affecting responders more strongly, or both).
</p><p>This close association of placebo effects with RCTs has a profound impact on how placebo effects are understood and valued in the scientific community.<sup id="cite_ref-Blasi,_Zelda_Di_et_al.,_2001_4-0" class="reference"><a href="#cite_note-Blasi,_Zelda_Di_et_al.,_2001-4">&#91;4&#93;</a></sup>
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Methodology"><span class="tocnumber">1</span> <span class="toctext">Methodology</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Blinding"><span class="tocnumber">1.1</span> <span class="toctext">Blinding</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Natural_history_groups"><span class="tocnumber">1.2</span> <span class="toctext">Natural history groups</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Indexing"><span class="tocnumber">1.3</span> <span class="toctext">Indexing</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Implementation_issues"><span class="tocnumber">2</span> <span class="toctext">Implementation issues</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Adherence"><span class="tocnumber">2.1</span> <span class="toctext">Adherence</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Unblinding"><span class="tocnumber">2.2</span> <span class="toctext">Unblinding</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#History"><span class="tocnumber">3</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#James_Lind_and_scurvy"><span class="tocnumber">3.1</span> <span class="toctext">James Lind and scurvy</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Animal_magnetism"><span class="tocnumber">3.2</span> <span class="toctext">Animal magnetism</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Perkins_tractors"><span class="tocnumber">3.3</span> <span class="toctext">Perkins tractors</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Flint_and_placebo_active_treatment_comparison"><span class="tocnumber">3.4</span> <span class="toctext">Flint and placebo active treatment comparison</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Jellinek_and_headache_remedy_ingredients"><span class="tocnumber">3.5</span> <span class="toctext">Jellinek  and headache remedy ingredients</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#MRC_and_randomized_trials"><span class="tocnumber">3.6</span> <span class="toctext">MRC and randomized trials</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-15"><a href="#Declaration_of_Helsinki"><span class="tocnumber">4</span> <span class="toctext">Declaration of Helsinki</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#Non-drug_treatments"><span class="tocnumber">5</span> <span class="toctext">Non-drug treatments</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-18"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-19"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Methodology">Methodology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=1" title="Edit section: Methodology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Blinding">Blinding</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=2" title="Edit section: Blinding">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Blinded_experiment" title="Blinded experiment">Blinded experiment</a></div>
<p>Blinding is the withholding of information from participants which may influence them in some way until after the experiment is complete. Good blinding may reduce or eliminate experimental <a href="/wiki/Bias" title="Bias">biases</a> such as <a href="/wiki/Confirmation_bias" title="Confirmation bias">confirmation bias</a>, the <a href="/wiki/Placebo_effect" class="mw-redirect" title="Placebo effect">placebo effect</a>, the <a href="/wiki/Observer-expectancy_effect" title="Observer-expectancy effect">observer effect</a>, and others. A blind can be imposed on any participant of an experiment, including subjects, researchers, technicians, data analysts, and evaluators. In some cases, while blinding would be useful, it is impossible or unethical. For example, is not possible to blind a patient to their treatment in a physical therapy intervention. A good <a href="/wiki/Clinical_protocol" class="mw-redirect" title="Clinical protocol">clinical protocol</a> ensures that blinding is as effective as possible within ethical and practical constrains.
</p><p>During the course of an experiment, a participant becomes <a href="/wiki/Unblinding" class="mw-redirect" title="Unblinding">unblinded</a> if they deduce or otherwise obtain information that has been masked to them. Unblinding that occurs before the conclusion of a study is a source of experimental error, as the bias that was eliminated by blinding is re-introduced. Unblinding is common in blind experiments, and must be measured and reported.
</p>
<h3><span class="mw-headline" id="Natural_history_groups">Natural history groups</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=3" title="Edit section: Natural history groups">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The practice of using an additional <a href="/wiki/Natural_history_group" title="Natural history group">natural history group</a> as the trial's so-called "<i>third arm</i>" has emerged; and trials are conducted using three <a href="/wiki/Randomized_clinical_trial" class="mw-redirect" title="Randomized clinical trial">randomly selected</a>, equally matched trial groups, Reilly<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">&#91;5&#93;</a></sup> wrote: "<i>... it is necessary to remember the adjective ‘random’ [in the term ‘random sample’] should apply to the method of drawing the sample and not to the sample itself.</i>".
</p>
<ul><li>The <b>Active drug</b> group (<b>A</b>): who receive the active test drug.</li>
<li>The <b>Placebo drug</b> group (<b>P</b>): who receive a placebo drug that simulates the active drug.</li>
<li>The <b>Natural history</b> group (<b>NH</b>): who receive no treatment of any kind (and whose condition, therefore, is allowed to run its <i>natural</i> course).</li></ul>
<p>The outcomes within each group are observed, and compared with each other, allowing us to measure:
</p>
<ul><li>The efficacy of the active drug's <b>treatment</b>: the difference between <b>A</b> and <b>NH</b> (i.e., <b>A-NH</b>).</li>
<li>The efficacy of the active drug's <b>active ingredient</b>: the difference between <b>A</b> and <b>P</b> (i.e., <b>A-P</b>).</li>
<li>The magnitude of the <b>placebo response</b>: the difference between <b>P</b> and <b>NH</b> (i.e., <b>P-NH</b>).</li></ul>
<p>It is a matter of interpretation whether the value of <b>P-NH</b> indicates the <i>efficacy of the entire treatment process</i> or the <i>magnitude of the "placebo response"</i>. The results of these comparisons then determine whether or not a particular drug is considered efficacious.
</p><p>Natural-History groups yield useful information when separate groups of subjects are used in a parallel or longitudinal study design. In <a href="/wiki/Crossover_studies" class="mw-redirect" title="Crossover studies">crossover studies</a>, however, where each subject undergoes both treatments in succession, the natural history of the chronic condition under investigation (e.g., progression) is well understood, with the study's duration being chosen such that the condition's intensity will be more or less stable over that duration.  (Wang et al provide the example of late-phase diabetes, whose natural history is long enough that even a crossover study lasting 1 year is acceptable. <sup id="cite_ref-6" class="reference"><a href="#cite_note-6">&#91;6&#93;</a></sup>) In these circumstances, a natural history group is not expected to yield useful information.
</p>
<h3><span class="mw-headline" id="Indexing">Indexing</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=4" title="Edit section: Indexing">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In certain clinical trials of particular drugs, it may happen that the level of the "placebo responses" manifested by the trial's subjects are either considerably higher or lower (in relation to the "active" drug's effects) than one would expect from other trials of similar drugs. In these cases, <a href="/wiki/Ceteris_paribus" title="Ceteris paribus">with all other things being equal</a>, it is reasonable to conclude that:
</p>
<ul><li>the degree to which there is a <b>considerably higher</b> level of "placebo response" than one would expect is an index of the degree to which the drug's <i>active ingredient</i> is <b>not efficacious</b>.</li>
<li>the degree to which there is a <b>considerably lower</b> level of "placebo response" than one would expect is an index of the degree to which, in some particular way, the <i>placebo</i> is <b>not simulating</b> the active drug in an appropriate way.</li></ul>
<p>However, in particular cases such as the use of Cimetidine to treat ulcers, a significant level of placebo response can also prove to be an index of how much the treatment has been directed at a wrong target.
</p>
<h2><span class="mw-headline" id="Implementation_issues">Implementation issues</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=5" title="Edit section: Implementation issues">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Adherence">Adherence</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=6" title="Edit section: Adherence">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The Coronary Drug Project<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">&#91;7&#93;</a></sup> was intended to study the safety and effectiveness of drugs for long-term treatment of coronary heart disease in men. Those in the placebo group who adhered to the placebo treatment (took the placebo regularly as instructed) showed nearly half the <a href="/wiki/Mortality_rate" title="Mortality rate">mortality rate</a> as those who were not adherent.
A similar study of women similarly found survival was nearly 2.5 times greater for those who adhered to their placebo.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup> This apparent placebo effect may have occurred because:
</p>
<ul><li>Adhering to the protocol had a psychological effect, i.e. genuine placebo effect.</li>
<li>People who were already healthier were more able or more inclined to follow the protocol.</li>
<li>Compliant people were more diligent and health-conscious in all aspects of their lives.</li></ul>
<h3><span class="mw-headline" id="Unblinding">Unblinding</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=7" title="Edit section: Unblinding">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Unblinding" class="mw-redirect" title="Unblinding">Unblinding</a></div>
<p>In some cases, a study participant may deduce or otherwise obtain information that has been blinded to them. For example, a patient taking a psychoactive drug may recognize that they are taking a drug. When this occurs, it is called <a href="/wiki/Unblinding" class="mw-redirect" title="Unblinding">unblinding</a>. This kind of unblinding can be reduced with the use of an <a href="/wiki/Active_placebo" title="Active placebo">active placebo</a>, which is a drug that produces effects similar to the active drug, making it more difficult for patients to determine which group they are in.
</p><p>An active placebo was used in the <a href="/wiki/Marsh_Chapel_Experiment" title="Marsh Chapel Experiment">Marsh Chapel Experiment</a>, a <a href="/wiki/Blinded_experiment" title="Blinded experiment">blinded study</a> in which the experimental group received the <a href="/wiki/Psychedelic_drug" title="Psychedelic drug">psychedelic</a> substance <a href="/wiki/Psilocybin" title="Psilocybin">psilocybin</a> while the control group received a large dose of <a href="/wiki/Niacin" title="Niacin">niacin</a>, a substance that produces noticeable physical effects intended to lead the control subjects to believe they had received the psychoactive drug.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=8" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">For broader coverage of this topic, see <a href="/wiki/Placebo_in_history" title="Placebo in history">Placebo in history</a>.</div>
<h3><span class="mw-headline" id="James_Lind_and_scurvy">James Lind and scurvy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=9" title="Edit section: James Lind and scurvy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:152px;"><a href="/wiki/File:James_lind.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/James_lind.jpg/150px-James_lind.jpg" decoding="async" width="150" height="191" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/James_lind.jpg/225px-James_lind.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/James_lind.jpg/300px-James_lind.jpg 2x" data-file-width="350" data-file-height="445" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:James_lind.jpg" class="internal" title="Enlarge"></a></div>A portrait of Scottish doctor James Lind (1716-1794)</div></div></div><p>In 1747, <a href="/wiki/James_Lind_(physician)" class="mw-redirect" title="James Lind (physician)">James Lind</a> (1716–1794), the <a href="/wiki/Ship%27s_doctor" class="mw-redirect" title="Ship&#39;s doctor">ship's doctor</a> on <a href="/wiki/HMS_Salisbury" title="HMS Salisbury">HMS Salisbury</a>, conducted the first <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trial</a> when he investigated the efficacy of <a href="/wiki/Citrus_fruit" class="mw-redirect" title="Citrus fruit">citrus fruit</a> in cases of <a href="/wiki/Scurvy" title="Scurvy">scurvy</a>. He randomly divided twelve scurvy patients, whose "cases were as similar as I could have them", into six pairs. Each pair was given a different remedy.  According to Lind’s 1753 <i>Treatise on the Scurvy in Three Parts Containing an Inquiry into the Nature, Causes, and Cure of the Disease, Together with a Critical and Chronological View of what has been Published of the Subject</i>, the remedies were: one quart of <a href="/wiki/Cider" title="Cider">cider</a> per day, twenty-five drops of elixir <a href="/wiki/Vitriol" title="Vitriol">vitriol</a> (<a href="/wiki/Sulfuric_acid" title="Sulfuric acid">sulfuric acid</a>) three times a day, two spoonfuls of <a href="/wiki/Vinegar" title="Vinegar">vinegar</a> three times a day, a course of sea-water (half a <a href="/wiki/Pint" title="Pint">pint</a> every day), two <a href="/wiki/Orange_(fruit)" title="Orange (fruit)">oranges</a> and one <a href="/wiki/Lemon" title="Lemon">lemon</a> each day, and <a href="/wiki/Electuary" title="Electuary">electuary</a>, (a mixture containing <a href="/wiki/Garlic" title="Garlic">garlic</a>, <a href="/wiki/Mustard_(condiment)" title="Mustard (condiment)">mustard</a>, <a href="/wiki/Balsam_of_Peru" title="Balsam of Peru">balsam of Peru</a>, and <a href="/wiki/Myrrh" title="Myrrh">myrrh</a>).<sup id="cite_ref-Lind_10-0" class="reference"><a href="#cite_note-Lind-10">&#91;10&#93;</a></sup>
</p><p>He noted that the pair who had been given the oranges and lemons were so restored to health within six days of treatment that one of them returned to duty, and the other was well enough to attend the rest of the sick.<sup id="cite_ref-Lind_10-1" class="reference"><a href="#cite_note-Lind-10">&#91;10&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Animal_magnetism">Animal magnetism</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=10" title="Edit section: Animal magnetism">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 1784, the <a href="/wiki/Royal_Commission_on_Animal_Magnetism" title="Royal Commission on Animal Magnetism">French Royal Commission investigated the existence of animal magnetism</a>, comparing the effects of allegedly "magnetized" water with that of plain water.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12">&#91;12&#93;</a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup>
It did not examine the practices of <a href="/wiki/Franz_Mesmer" title="Franz Mesmer">Franz Mesmer</a>, but examined the significantly different practices of his associate Charles d'Eslon (1739–1786).
</p>
<h3><span class="mw-headline" id="Perkins_tractors">Perkins tractors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=11" title="Edit section: Perkins tractors">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 1799, <a href="/wiki/John_Haygarth" title="John Haygarth">John Haygarth</a><sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup> investigated the efficacy of medical instruments called "<a href="/wiki/Perkins_tractors" class="mw-redirect" title="Perkins tractors">Perkins tractors</a>", by comparing the results from <i>dummy</i> wooden tractors with a set of allegedly "active" metal tractors, and published his findings in a book <i>On the Imagination as a Cause &amp; as a Cure of Disorders of the Body</i>.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Flint_and_placebo_active_treatment_comparison">Flint and placebo active treatment comparison</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=12" title="Edit section: Flint and placebo active treatment comparison">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 1863 <a href="/wiki/Austin_Flint_murmur" title="Austin Flint murmur">Austin Flint</a> (1812–1886) conducted the first-ever trial that directly compared the efficacy of a dummy simulator with that of an active treatment; although Flint's examination did not compare the two against each other in the same trial. Even so, this was a significant departure from the (then) customary practice of contrasting the consequences of an active treatment with what Flint described as "<i>the natural history of [an untreated] disease</i>".<sup id="cite_ref-Finkt_17-0" class="reference"><a href="#cite_note-Finkt-17">&#91;17&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 18">&#58;&#8202;18&#8202;</span></sup>
</p><p>
Flint’s paper is the first time that he terms "placebo" or "placeboic remedy" were used to refer to a dummy simulator in a clinical trial.<style data-mw-deduplicate="TemplateStyles:r996844942">.mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0}</style></p><blockquote class="templatequote"><p>… to secure the moral effect of a remedy given specially for the disease, the patients were placed on the use of a placebo which consisted, in nearly all of the cases, of the tincture of <a href="/wiki/Quassia" title="Quassia">quassia</a>, very largely diluted. This was given regularly, and became well known in my wards as the placeboic remedy for <a href="/wiki/Rheumatism" title="Rheumatism">rheumatism</a>.</p></blockquote>
<p>Flint<sup id="cite_ref-Finkt_17-1" class="reference"><a href="#cite_note-Finkt-17">&#91;17&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 21">&#58;&#8202;21&#8202;</span></sup> treated 13 hospital inmates who had <a href="/wiki/Rheumatic_fever" title="Rheumatic fever">rheumatic fever</a>; 11 were "<a href="/wiki/Acute_(medical)" class="mw-redirect" title="Acute (medical)">acute</a>", and 2 were "sub-acute". He then compared the results of his dummy "placeboic remedy"  with that of the active treatment’s already well-understood results. (Flint had previously tested, and reported on, the active treatment’s efficacy.) There was no significant difference between the results of the active treatment and his "placeboic remedy" in 12 of the cases in terms of disease duration, duration of convalescence, number of joints affected, and emergence of <a href="/wiki/Complication_(medicine)" title="Complication (medicine)">complications</a>.<sup id="cite_ref-Finkt_17-2" class="reference"><a href="#cite_note-Finkt-17">&#91;17&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 32–34">&#58;&#8202;32–34&#8202;</span></sup> In the thirteenth case, Flint expressed some doubt whether the particular complications that had emerged (namely, <a href="/wiki/Pericarditis" title="Pericarditis">pericarditis</a>, <a href="/wiki/Endocarditis" title="Endocarditis">endocarditis</a>, and <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>) would have been prevented if that subject had been immediately given the "active treatment".<sup id="cite_ref-Finkt_17-3" class="reference"><a href="#cite_note-Finkt-17">&#91;17&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 36">&#58;&#8202;36&#8202;</span></sup>
</p>
<h3><span class="mw-headline" id="Jellinek_and_headache_remedy_ingredients">Jellinek  and headache remedy ingredients</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=13" title="Edit section: Jellinek and headache remedy ingredients">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Jellinek in 1946<sup id="cite_ref-Jellinke_18-0" class="reference"><a href="#cite_note-Jellinke-18">&#91;18&#93;</a></sup> was asked to test whether or not the headache drug's overall efficacy would be reduced if certain ingredients were removed. In post-<a href="/wiki/World_War_II" title="World War II">World War II</a> 1946, pharmaceutical chemicals were restricted, and one U.S. headache remedy manufacturer sold a drug composed of three ingredients: <b>a</b>, <b>b</b>, and <b>c</b>, and chemical <b>b</b> was in particular short supply.
</p><p>Jellinek set up a complex trial involving 199 subjects, all of whom suffered from "<i>frequent headaches</i>". The subjects were randomly divided  into four test groups. He prepared four test drugs, involving various <a href="/wiki/Permutation" title="Permutation">permutations</a> of the three drug constituents, with a placebo as a <a href="/wiki/Scientific_control" title="Scientific control">scientific control</a>. The structure of this trial is significant because, in those days, the only time placebos were ever used "<i>was to express the efficacy or non-efficacy of a drug in terms of "how much better" the drug was than the "placebo</i>".<sup id="cite_ref-Jellinke_18-1" class="reference"><a href="#cite_note-Jellinke-18">&#91;18&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 88">&#58;&#8202;88&#8202;</span></sup> (Note that the trial conducted by Austin Flint is an example of such a drug efficacy vs. placebo efficacy trial.) The four test drugs were identical in shape, size, colour and taste:
</p>
<ul><li>Drug <b>A</b>: contained <b>a</b>, <b>b</b>, and <b>c</b>.</li>
<li>Drug <b>B</b>: contained <b>a</b> and <b>c</b>.</li>
<li>Drug <b>C</b>: contained <b>a</b> and <b>b</b>.</li>
<li>Drug <b>D</b>: a 'simulator', contained "ordinary <a href="/wiki/Lactic_acid" title="Lactic acid">lactate</a>".</li></ul>
<p>Each time a subject had a headache, they took their group’s designated test drug, and recorded whether their headache had been relieved (or not). Although "some subjects had only three headaches in the course of a two-week period while others had up to ten attacks in the same period", the data showed a "great consistency" across all subjects<sup id="cite_ref-Jellinke_18-2" class="reference"><a href="#cite_note-Jellinke-18">&#91;18&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 88">&#58;&#8202;88&#8202;</span></sup> Every two weeks the groups’ drugs were changed; so that by the end of eight weeks, all groups had tested all the drugs. The stipulated drug (i.e., <b>A</b>, <b>B</b>, <b>C</b>, or <b>D</b>) was taken as often as necessary over each two-week period, and the two-week sequences for each of the four groups were:
</p>
<ol><li><b>A</b>, <b>B</b>, <b>C</b>, <b>D</b></li>
<li><b>B</b>, <b>A</b>, <b>D</b>, <b>C</b></li>
<li><b>C</b>, <b>D</b>, <b>A</b>, <b>B</b></li>
<li><b>D</b>, <b>C</b>, <b>B</b>, <b>A</b>.</li></ol>
<p>Over the entire population of 199 subjects, there were 120 "<i>subjects reacting to placebo</i>" and  79 "<i>subjects not reacting to placebo</i>".<sup id="cite_ref-Jellinke_18-3" class="reference"><a href="#cite_note-Jellinke-18">&#91;18&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 89">&#58;&#8202;89&#8202;</span></sup>
</p><p>On initial analysis, there was no difference between the self-reported "success rates" of Drugs <b>A</b>, <b>B</b>, and <b>C</b> (84%, 80%, and 80% respectively) (the "success rate" of the simulating placebo Drug <b>D</b> was 52%); and, from this, it appeared that ingredient <b>b</b> was completely unnecessary.
</p><p>However, further analysis on the trial demonstrated that ingredient <b>b</b> made a significant contribution to the remedy’s efficacy. Examining his data, Jellinek discovered that there was a very significant difference in responses between the 120 placebo-responders and the 79 non-responders. The 79 non-responders' reports showed that if they were considered as an entirely separate group, there was a significant difference the "success rates" of Drugs <b>A</b>, <b>B</b>, and <b>C</b>: viz., 88%, 67%, and 77%, respectively. And because this significant difference in relief from the test drugs could only be attributed to the presence or absence of ingredient <b>b</b>, he concluded that ingredient <b>b</b> was essential.
</p><p>Two conclusions came from this trial:
</p>
<ul><li>Jellinek,<sup id="cite_ref-Jellinke_18-4" class="reference"><a href="#cite_note-Jellinke-18">&#91;18&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 90">&#58;&#8202;90&#8202;</span></sup> having identified 120 "placebo reactors", went on to suppose that all of them may have been suffering from either "<i>psychological headaches</i>" (with or without attendant "<i><a href="/wiki/Hypochondria" class="mw-redirect" title="Hypochondria">hypochondriasis</a></i>")  or "<i>true physiological headaches [which were] accessible to suggestion</i>". Thus, according to this view, the degree to which a "placebo response" is present tends to be an index of the <a href="/wiki/Psychosomatic_illness" class="mw-redirect" title="Psychosomatic illness">psychogenic</a> origins of the condition in question.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup><sup class="reference nowrap"><span title="Page / location: 777">&#58;&#8202;777&#8202;</span></sup></li>
<li>It indicated that, whilst any given placebo was inert, a <i>responder</i> to that particular placebo may be responding for a wide number of reasons unconnected with the drug's active ingredients; and, from this, it could be important to pre-<a href="/wiki/Screening_(medicine)" title="Screening (medicine)">screen</a> potential test populations, and treat those manifesting a placebo-response as a special group, or remove them altogether from the test population!</li></ul>
<h3><span class="mw-headline" id="MRC_and_randomized_trials">MRC and randomized trials</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=14" title="Edit section: MRC and randomized trials">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>It used to be thought<sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup> that the first-ever randomized clinical trial was the trial<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup> conducted by the <a href="/wiki/Medical_Research_Council_(UK)" class="mw-redirect" title="Medical Research Council (UK)">Medical Research Council</a> (MRC) in 1948 into the efficacy of <a href="/wiki/Streptomycin" title="Streptomycin">streptomycin</a> in the treatment of <a href="/wiki/Pulmonary_tuberculosis" class="mw-redirect" title="Pulmonary tuberculosis">pulmonary tuberculosis</a>. In this trial, there were two test groups:
</p>
<ol><li>those "<i>treated by <a href="/wiki/Streptomycin" title="Streptomycin">streptomycin</a> and <a href="/wiki/Bed-rest" class="mw-redirect" title="Bed-rest">bed-rest</a></i>", and</li>
<li>those "<i>[treated] by bed-rest alone</i>" (the control group).</li></ol>
<p>What made this trial novel was that the subjects were randomly allocated to their test groups. The up-to-that-time practice was to allocate subjects alternately to each group, based on the order in which they presented for treatment. This practice could be <a href="/wiki/Bias_of_an_estimator" title="Bias of an estimator">biased</a>, because those admitting each patient knew to which group that patient would be allocated (and so the decision to admit or not admit a specific patient might be influenced by the experimenter's knowledge of the nature of their illness, and their knowledge of the group to which they would occupy).
</p><p>Recently, an earlier MRC trial on the antibiotic patulin on the course of common colds<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup> has been suggested to have been the first randomized trial.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup> Another early and until recently overlooked randomized trial was published on strophanthin in a local Finnish journal in 1946.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Declaration_of_Helsinki">Declaration of Helsinki</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=15" title="Edit section: Declaration of Helsinki">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>From the time of the <a href="/wiki/Hippocratic_Oath" title="Hippocratic Oath">Hippocratic Oath</a> questions of the ethics of medical practice have been widely discussed, and codes of practice have been gradually developed as a response to advances in scientific medicine.
The <b><a href="/wiki/Nuremberg_Code" title="Nuremberg Code">Nuremberg Code</a></b>, which was issued in August 1947, as a consequence of the so-called <a href="/wiki/Doctors%27_Trial" class="mw-redirect" title="Doctors&#39; Trial">Doctors' Trial</a> which examined the <a href="/wiki/Nazi_human_experimentation" title="Nazi human experimentation">human experimentation</a> conducted by <a href="/wiki/Nazism" title="Nazism">Nazi</a> doctors during <a href="/wiki/World_War_II" title="World War II">World War II</a>, offers ten principles for legitimate medical research, including <a href="/wiki/Informed_consent" title="Informed consent">informed consent</a>, absence of <a href="/wiki/Coercion" title="Coercion">coercion</a>, and <a href="/wiki/Beneficence_(ethics)" title="Beneficence (ethics)">beneficence</a> towards experiment participants.
</p><p>In 1964, the <a href="/wiki/World_Medical_Association" title="World Medical Association">World Medical Association</a> issued the <b><a href="/wiki/Declaration_of_Helsinki" title="Declaration of Helsinki">Declaration of Helsinki</a></b>,<a rel="nofollow" class="external autonumber" href="https://web.archive.org/web/20090220183350/http://www.wma.net/e/policy/b3.htm">[2]</a> which specifically limited its directives to health research by physicians, and emphasized a number of  additional conditions in circumstances where "<i>medical research is combined with medical care</i>".
The significant difference between the 1947 <b>Nuremberg Code</b> and the 1964 <b>Declaration of Helsinki</b> is that the first was a set of principles that was <i>suggested</i> <b>to</b> the medical profession by the "Doctors’ Trial" judges, whilst the second was <i>imposed</i> <b>by</b> the medical profession upon itself.
Paragraph 29 of the Declaration makes specific mention of placebos:
</p>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r996844942"/><blockquote class="templatequote"><p>29. The benefits, risks, burdens and effectiveness of a new method should be tested against those of the best current prophylactic, diagnostic, and therapeutic methods. This does not exclude the use of placebo, or no treatment, in studies where no proven prophylactic, diagnostic or therapeutic method exists.</p></blockquote>
<p>In 2002, World Medical Association issued the following elaborative announcement:
</p>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r996844942"/><blockquote class="templatequote"><p>Note of clarification on paragraph 29 of the WMA Declaration of Helsinki<br /><br />The WMA hereby reaffirms its position that extreme care must be taken in making use of a placebo-controlled trial and that in general this methodology should only be used in the absence of existing proven therapy. However, a placebo-controlled trial may be ethically acceptable, even if proven therapy is available, under the following circumstances:
</p><dl><dd>— Where for compelling and scientifically sound methodological reasons its use is necessary to determine the efficacy or safety of a prophylactic, diagnostic or therapeutic method; or</dd>
<dd>— Where a prophylactic, diagnostic or therapeutic method is being investigated for a minor condition and the patients who receive placebo will not be subject to any additional risk of serious or irreversible harm.</dd></dl><p>
All other provisions of the Declaration of Helsinki must be adhered to, especially the need for appropriate ethical and scientific review.</p></blockquote>
<p>In addition to the requirement for informed consent from all drug-trial participants, it is also  standard practice to inform all test subjects that they may receive the drug being tested or that they may receive the placebo.
</p>
<h2><span class="mw-headline" id="Non-drug_treatments">Non-drug treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=16" title="Edit section: Non-drug treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>"Talking therapies" (such as <a href="/wiki/Hypnotherapy" title="Hypnotherapy">hypnotherapy</a>, <a href="/wiki/Psychotherapy" title="Psychotherapy">psychotherapy</a>, <a href="/wiki/Counseling" class="mw-redirect" title="Counseling">counseling</a>, and non-drug <a href="/wiki/Psychiatry" title="Psychiatry">psychiatry</a>) are now required to have scientific <a href="/wiki/Verification_and_validation" title="Verification and validation">validation</a> by clinical trial. However, there is controversy over what might or might not be an appropriate placebo for such therapeutic treatments. Furthermore, there are methodological challenges such as blinding the person providing the psychological non-drug intervention. In 2005, the <i>Journal of Clinical Psychology</i>, devoted an issue <sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup> to the issue of "<i>The Placebo Concept in Psychotherapy</i>" that contained a range of contributions to this question. As the abstract of one paper noted: "Unlike within the domain of medicine, in which the logic of placebos is relatively straightforward, the concept of placebo as applied to psychotherapy is fraught with both conceptual and practical problems."<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=17" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r998391716">.mw-parser-output .div-col{margin-top:0.3em;column-width:30em}.mw-parser-output .div-col-small{font-size:90%}.mw-parser-output .div-col-rules{column-rule:1px solid #aaa}.mw-parser-output .div-col dl,.mw-parser-output .div-col ol,.mw-parser-output .div-col ul{margin-top:0}.mw-parser-output .div-col li,.mw-parser-output .div-col dd{page-break-inside:avoid;break-inside:avoid-column}</style><div class="div-col" style="column-width: 30em;">
<ul><li><a href="/wiki/Academic_clinical_trials" class="mw-redirect" title="Academic clinical trials">Academic clinical trials</a></li>
<li><a href="/wiki/Bioethics" title="Bioethics">Bioethics</a></li>
<li><a href="/wiki/Blinded_experiment" title="Blinded experiment">Blinded experiment</a></li>
<li><a href="/wiki/Clinical_data_acquisition" title="Clinical data acquisition">Clinical data acquisition</a></li>
<li><a href="/wiki/Clinical_data_management" title="Clinical data management">Clinical trial management</a></li>
<li><a href="/wiki/Confounding_factor" class="mw-redirect" title="Confounding factor">Confounding factor</a></li>
<li><a href="/wiki/Experimental_design" class="mw-redirect" title="Experimental design">Experimental design</a></li>
<li><a href="/wiki/Medical_ethics" title="Medical ethics">Medical ethics</a></li>
<li><a href="/wiki/Philosophy_of_medicine" title="Philosophy of medicine">Philosophy of medicine</a></li>
<li><a href="/wiki/Placebo" title="Placebo">Placebo</a></li>
<li><a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">Randomized controlled trial</a></li>
<li><a href="/wiki/Royal_Commission_on_Animal_Magnetism" title="Royal Commission on Animal Magnetism">Royal Commission on Animal Magnetism</a></li>
<li><a href="/wiki/Scientific_control" title="Scientific control">Scientific control</a></li>
<li><a href="/wiki/Scientific_method" title="Scientific method">Scientific method</a></li></ul>
</div>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=18" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist reflist-columns references-column-width" style="column-width: 30em;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1067248974">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFGaddum_JH1954" class="citation journal cs1">Gaddum JH (March 1954). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1918604">"Clinical pharmacology"</a>. <i>Proc. R. Soc. Med</i>. <b>47</b> (3): 195–204. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1918604">1918604</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/13155508">13155508</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proc.+R.+Soc.+Med.&amp;rft.atitle=Clinical+pharmacology&amp;rft.volume=47&amp;rft.issue=3&amp;rft.pages=195-204&amp;rft.date=1954-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1918604%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F13155508&amp;rft.au=Gaddum+JH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1918604&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChamblessHollon1998" class="citation journal cs1">Chambless DL, Hollon SD (February 1998). <a rel="nofollow" class="external text" href="http://content.apa.org/journals/ccp/66/1/7">"Defining empirically supported therapies"</a>. <i>J Consult Clin Psychol</i>. <b>66</b> (1): 7–18. <a href="/wiki/CiteSeerX_(identifier)" class="mw-redirect" title="CiteSeerX (identifier)">CiteSeerX</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.586.4638">10.1.1.586.4638</a></span>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1037%2F0022-006X.66.1.7">10.1037/0022-006X.66.1.7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9489259">9489259</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Consult+Clin+Psychol&amp;rft.atitle=Defining+empirically+supported+therapies&amp;rft.volume=66&amp;rft.issue=1&amp;rft.pages=7-18&amp;rft.date=1998-02&amp;rft_id=%2F%2Fciteseerx.ist.psu.edu%2Fviewdoc%2Fsummary%3Fdoi%3D10.1.1.586.4638%23id-name%3DCiteSeerX&amp;rft_id=info%3Apmid%2F9489259&amp;rft_id=info%3Adoi%2F10.1037%2F0022-006X.66.1.7&amp;rft.aulast=Chambless&amp;rft.aufirst=DL&amp;rft.au=Hollon%2C+SD&amp;rft_id=http%3A%2F%2Fcontent.apa.org%2Fjournals%2Fccp%2F66%2F1%2F7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLohrOlatunjiParkerDeMaio2005" class="citation journal cs1">Lohr JM, Olatunji BO, Parker L, DeMaio C (July 2005). "Experimental analysis of specific treatment factors: efficacy and practice implications". <i>J Clin Psychol</i>. <b>61</b> (7): 819–34. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fjclp.20128">10.1002/jclp.20128</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15827994">15827994</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Clin+Psychol&amp;rft.atitle=Experimental+analysis+of+specific+treatment+factors%3A+efficacy+and+practice+implications&amp;rft.volume=61&amp;rft.issue=7&amp;rft.pages=819-34&amp;rft.date=2005-07&amp;rft_id=info%3Adoi%2F10.1002%2Fjclp.20128&amp;rft_id=info%3Apmid%2F15827994&amp;rft.aulast=Lohr&amp;rft.aufirst=JM&amp;rft.au=Olatunji%2C+BO&amp;rft.au=Parker%2C+L&amp;rft.au=DeMaio%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-Blasi,_Zelda_Di_et_al.,_2001-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-Blasi,_Zelda_Di_et_al.,_2001_4-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDi_BlasiHarknessEdzardGeorgiou2019" class="citation journal cs1">Di Blasi, Zelda; Harkness, Elaine; Edzard, Ernst; Georgiou, Amanda; Kleijnen, Jos (2019). "Influence of context effects on health outcomes: a systematic review". <i>The Lancet</i>. <b>357</b> (9258): 757–762. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2800%2904169-6">10.1016/S0140-6736(00)04169-6</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11253970">11253970</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6740675">6740675</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet&amp;rft.atitle=Influence+of+context+effects+on+health+outcomes%3A+a+systematic+review&amp;rft.volume=357&amp;rft.issue=9258&amp;rft.pages=757-762&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6740675%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11253970&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2800%2904169-6&amp;rft.aulast=Di+Blasi&amp;rft.aufirst=Zelda&amp;rft.au=Harkness%2C+Elaine&amp;rft.au=Edzard%2C+Ernst&amp;rft.au=Georgiou%2C+Amanda&amp;rft.au=Kleijnen%2C+Jos&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFReilly2002" class="citation journal cs1">Reilly, David (2002). <a rel="nofollow" class="external text" href="http://student.bmj.com/issues/02/02/education/12.php">"Creative consulting: what modifies a healing response"</a>. <i>Student BMJ</i>. <b>10</b>: 1–44.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Student+BMJ&amp;rft.atitle=Creative+consulting%3A+what+modifies+a+healing+response&amp;rft.volume=10&amp;rft.pages=1-44&amp;rft.date=2002&amp;rft.aulast=Reilly&amp;rft.aufirst=David&amp;rft_id=http%3A%2F%2Fstudent.bmj.com%2Fissues%2F02%2F02%2Feducation%2F12.php&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span> p.28</span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"> Wang T, Malone J, Fu H, Heilmann C, Qu Y, Huster WJ. Crossover design and its application in late-phase diabetes studies. J Diabetes. 2016 Sep;8(5):610-8. PubMed ID: <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pubmed/27100270">27100270</a> </span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCoronary_Drug_Project_Research_Group1980" class="citation journal cs1">Coronary Drug Project Research Group (October 1980). "Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project". <i>N. Engl. J. Med</i>. <b>303</b> (18): 1038–41. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJM198010303031804">10.1056/NEJM198010303031804</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/6999345">6999345</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.atitle=Influence+of+adherence+to+treatment+and+response+of+cholesterol+on+mortality+in+the+coronary+drug+project&amp;rft.volume=303&amp;rft.issue=18&amp;rft.pages=1038-41&amp;rft.date=1980-10&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM198010303031804&amp;rft_id=info%3Apmid%2F6999345&amp;rft.au=Coronary+Drug+Project+Research+Group&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGallagherViscoli,_C._M.Horwitz,_R._I.1993" class="citation journal cs1">Gallagher, E. J.; Viscoli, C. M.; Horwitz, R. I. (1993). "The relationship of treatment adherence to the risk of death after myocardial infarction in women". <i>Journal of the American Medical Association</i>. <b>270</b> (6): 742–4. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.270.6.742">10.1001/jama.270.6.742</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8336377">8336377</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.atitle=The+relationship+of+treatment+adherence+to+the+risk+of+death+after+myocardial+infarction+in+women&amp;rft.volume=270&amp;rft.issue=6&amp;rft.pages=742-4&amp;rft.date=1993&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.270.6.742&amp;rft_id=info%3Apmid%2F8336377&amp;rft.aulast=Gallagher&amp;rft.aufirst=E.+J.&amp;rft.au=Viscoli%2C+C.+M.&amp;rft.au=Horwitz%2C+R.+I.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHarmanMcKimMogarFadiman1966" class="citation journal cs1">Harman WW, McKim RH, Mogar RE, Fadiman J, Stolaroff MJ (August 1966). "Psychedelic agents in creative problem-solving: a pilot study". <i>Psychol Rep</i>. <b>19</b> (1): 211–27. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2466%2Fpr0.1966.19.1.211">10.2466/pr0.1966.19.1.211</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/5942087">5942087</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:16508547">16508547</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychol+Rep&amp;rft.atitle=Psychedelic+agents+in+creative+problem-solving%3A+a+pilot+study&amp;rft.volume=19&amp;rft.issue=1&amp;rft.pages=211-27&amp;rft.date=1966-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A16508547%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F5942087&amp;rft_id=info%3Adoi%2F10.2466%2Fpr0.1966.19.1.211&amp;rft.aulast=Harman&amp;rft.aufirst=WW&amp;rft.au=McKim%2C+RH&amp;rft.au=Mogar%2C+RE&amp;rft.au=Fadiman%2C+J&amp;rft.au=Stolaroff%2C+MJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-Lind-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lind_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lind_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDunn1997" class="citation journal cs1">Dunn, Peter M. (January 1, 1997). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1720613">"James Lind (1716-94) of Edinburgh and the treatment of scurvy"</a>. <i>Archives of Disease in Childhood: Fetal and Neonatal Edition</i>. <b>76</b> (1): F64–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Ffn.76.1.F64">10.1136/fn.76.1.F64</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1720613">1720613</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9059193">9059193</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Disease+in+Childhood%3A+Fetal+and+Neonatal+Edition&amp;rft.atitle=James+Lind+%281716-94%29+of+Edinburgh+and+the+treatment+of+scurvy&amp;rft.volume=76&amp;rft.issue=1&amp;rft.pages=F64-5&amp;rft.date=1997-01-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1720613%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9059193&amp;rft_id=info%3Adoi%2F10.1136%2Ffn.76.1.F64&amp;rft.aulast=Dunn&amp;rft.aufirst=Peter+M.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1720613&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGauld,_Alan1992" class="citation book cs1">Gauld, Alan (1992). <span class="cs1-lock-registration" title="Free registration required"><a rel="nofollow" class="external text" href="https://archive.org/details/historyofhypnoti0000gaul"><i>A history of hypnotism</i></a></span>. Cambridge, UK: Cambridge University Press. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-521-48329-2" title="Special:BookSources/978-0-521-48329-2"><bdi>978-0-521-48329-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=A+history+of+hypnotism&amp;rft.place=Cambridge%2C+UK&amp;rft.pub=Cambridge+University+Press&amp;rft.date=1992&amp;rft.isbn=978-0-521-48329-2&amp;rft.au=Gauld%2C+Alan&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fhistoryofhypnoti0000gaul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDonaldson_IM2005" class="citation journal cs1">Donaldson IM (December 2005). <a rel="nofollow" class="external text" href="http://www.jrsm.org/cgi/pmidlookup?view=long&amp;pmid=16319443">"Mesmer's 1780 proposal for a controlled trial to test his method of treatment using "animal magnetism"<span class="cs1-kern-right"></span>"</a>. <i>J R Soc Med</i>. <b>98</b> (12): 572–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1258%2Fjrsm.98.12.572">10.1258/jrsm.98.12.572</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1299353">1299353</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16319443">16319443</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+R+Soc+Med&amp;rft.atitle=Mesmer%27s+1780+proposal+for+a+controlled+trial+to+test+his+method+of+treatment+using+%22animal+magnetism%22&amp;rft.volume=98&amp;rft.issue=12&amp;rft.pages=572-5&amp;rft.date=2005-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1299353%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F16319443&amp;rft_id=info%3Adoi%2F10.1258%2Fjrsm.98.12.572&amp;rft.au=Donaldson+IM&amp;rft_id=http%3A%2F%2Fwww.jrsm.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D16319443&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBestNeuhauserSlavin2003" class="citation journal cs1">Best M, Neuhauser D, Slavin L (June 2003). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1743715">"Evaluating Mesmerism, Paris, 1784: the controversy over the blinded placebo controlled trials has not stopped"</a>. <i>Qual Saf Health Care</i>. <b>12</b> (3): 232–3. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fqhc.12.3.232">10.1136/qhc.12.3.232</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1743715">1743715</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12792017">12792017</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Qual+Saf+Health+Care&amp;rft.atitle=Evaluating+Mesmerism%2C+Paris%2C+1784%3A+the+controversy+over+the+blinded+placebo+controlled+trials+has+not+stopped&amp;rft.volume=12&amp;rft.issue=3&amp;rft.pages=232-3&amp;rft.date=2003-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1743715%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F12792017&amp;rft_id=info%3Adoi%2F10.1136%2Fqhc.12.3.232&amp;rft.aulast=Best&amp;rft.aufirst=M&amp;rft.au=Neuhauser%2C+D&amp;rft.au=Slavin%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1743715&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBooth_C2005" class="citation journal cs1">Booth C (August 2005). <a rel="nofollow" class="external text" href="http://jmb.rsmjournals.com/cgi/pmidlookup?view=long&amp;pmid=16059528">"The rod of Aesculapios: John Haygarth (1740–1827) and Perkins' metallic tractors"</a>. <i>J Med Biogr</i>. <b>13</b> (3): 155–61. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1258%2Fj.jmb.2005.04-01">10.1258/j.jmb.2005.04-01</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16059528">16059528</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J+Med+Biogr&amp;rft.atitle=The+rod+of+Aesculapios%3A+John+Haygarth+%281740%E2%80%931827%29+and+Perkins%27+metallic+tractors&amp;rft.volume=13&amp;rft.issue=3&amp;rft.pages=155-61&amp;rft.date=2005-08&amp;rft_id=info%3Adoi%2F10.1258%2Fj.jmb.2005.04-01&amp;rft_id=info%3Apmid%2F16059528&amp;rft.au=Booth+C&amp;rft_id=http%3A%2F%2Fjmb.rsmjournals.com%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D16059528&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span><sup class="noprint Inline-Template"><span style="white-space: nowrap;">&#91;<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title="&#160;Dead link tagged May 2020">permanent dead link</span></a></i>&#93;</span></sup></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGreen_SA2002" class="citation journal cs1">Green SA (December 2002). "The origins of modern clinical research". <i>Clin. Orthop. Relat. Res</i>. <b>405</b> (405): 311–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00003086-200212000-00039">10.1097/00003086-200212000-00039</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12461388">12461388</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Orthop.+Relat.+Res.&amp;rft.atitle=The+origins+of+modern+clinical+research&amp;rft.volume=405&amp;rft.issue=405&amp;rft.pages=311-9&amp;rft.date=2002-12&amp;rft_id=info%3Adoi%2F10.1097%2F00003086-200212000-00039&amp;rft_id=info%3Apmid%2F12461388&amp;rft.au=Green+SA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHaygarth,_J.1801" class="citation book cs1">Haygarth, J. (1801). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20080516075049/http://www.jameslindlibrary.org/trial_records/19th_Century/haygarth/pamphlet/haygarth_pamphlet.pdf"><i>Of the Imagination, as a Cause and as a Cure of Disorders of the Body; Exemplified by Fictitious Tractors, and Epidemical Convulsions (New Edition, with Additional Remarks)</i></a> <span class="cs1-format">(PDF)</span>. Bath: Crutwell. Archived from <a rel="nofollow" class="external text" href="http://www.jameslindlibrary.org/trial_records/19th_Century/haygarth/pamphlet/haygarth_pamphlet.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 2008-05-16<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-01-09</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Of+the+Imagination%2C+as+a+Cause+and+as+a+Cure+of+Disorders+of+the+Body%3B+Exemplified+by+Fictitious+Tractors%2C+and+Epidemical+Convulsions+%28New+Edition%2C+with+Additional+Remarks%29&amp;rft.place=Bath&amp;rft.pub=Crutwell&amp;rft.date=1801&amp;rft.au=Haygarth%2C+J.&amp;rft_id=http%3A%2F%2Fwww.jameslindlibrary.org%2Ftrial_records%2F19th_Century%2Fhaygarth%2Fpamphlet%2Fhaygarth_pamphlet.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-Finkt-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Finkt_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Finkt_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Finkt_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Finkt_17-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">Flint, A., "A Contribution Toward the Natural History of Articular Rheumatism, Consisting of a Report of Thirteen Cases Treated Solely with Palliative Measures", <i>American Journal of the Medical Sciences</i>, Vol.46, (July 1863), pp.17–36.
<a rel="nofollow" class="external autonumber" href="http://www.jameslindlibrary.org/trial_records/19th_Century/flint/flint_tp.html">[1]</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20090301050710/http://www.jameslindlibrary.org/trial_records/19th_Century/flint/flint_tp.html">Archived</a> 2009-03-01 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-Jellinke-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jellinke_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jellinke_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Jellinke_18-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Jellinke_18-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Jellinke_18-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text">Jellinek, E. M. <a rel="nofollow" class="external text" href="https://www.jstor.org/pss/3001983">JSTORE "Clinical Tests on Comparative Effectiveness of Analgesic Drugs"</a>, <i>Biometrics Bulletin</i>, Vol.2, No.5, (October 1946), pp.87–91.</span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLasagnaMostellervon_FelsingerBeecher1954" class="citation journal cs1">Lasagna L, Mosteller F, von Felsinger JM, Beecher HK (June 1954). "A study of the placebo response". <i>Am. J. Med</i>. <b>16</b> (6): 770–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2F0002-9343%2854%2990441-6">10.1016/0002-9343(54)90441-6</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/13158365">13158365</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Med.&amp;rft.atitle=A+study+of+the+placebo+response&amp;rft.volume=16&amp;rft.issue=6&amp;rft.pages=770-9&amp;rft.date=1954-06&amp;rft_id=info%3Adoi%2F10.1016%2F0002-9343%2854%2990441-6&amp;rft_id=info%3Apmid%2F13158365&amp;rft.aulast=Lasagna&amp;rft.aufirst=L&amp;rft.au=Mosteller%2C+F&amp;rft.au=von+Felsinger%2C+JM&amp;rft.au=Beecher%2C+HK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFYoshioka_A1998" class="citation journal cs1">Yoshioka A (October 1998). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1114162">"Use of randomisation in the Medical Research Council's clinical trial of streptomycin in pulmonary tuberculosis in the 1940s"</a>. <i>BMJ</i>. <b>317</b> (7167): 1220–3. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.317.7167.1220">10.1136/bmj.317.7167.1220</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1114162">1114162</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9794865">9794865</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Use+of+randomisation+in+the+Medical+Research+Council%27s+clinical+trial+of+streptomycin+in+pulmonary+tuberculosis+in+the+1940s&amp;rft.volume=317&amp;rft.issue=7167&amp;rft.pages=1220-3&amp;rft.date=1998-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1114162%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9794865&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.317.7167.1220&amp;rft.au=Yoshioka+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1114162&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation journal cs1"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2091872">"Streptomycin treatment of pulmonary tuberculosis"</a>. <i>Br Med J</i>. <b>2</b> (4582): 769–82. October 1948. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.2.4582.769">10.1136/bmj.2.4582.769</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2091872">2091872</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18890300">18890300</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Br+Med+J&amp;rft.atitle=Streptomycin+treatment+of+pulmonary+tuberculosis&amp;rft.volume=2&amp;rft.issue=4582&amp;rft.pages=769-82&amp;rft.date=1948-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2091872%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18890300&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.2.4582.769&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2091872&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span> <a rel="nofollow" class="external text" href="http://www.jameslindlibrary.org/trial_records/20th_Century/1940s/MRC_bmj/MRC_bmj_kp.html">see also</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20081025182124/http://www.jameslindlibrary.org/trial_records/20th_Century/1940s/MRC_bmj/MRC_bmj_kp.html">Archived</a> 2008-10-25 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPatulin_Clinical_Trials_Committee,_Medical_Research_Council2004" class="citation journal cs1">Patulin Clinical Trials Committee, Medical Research Council (April 2004). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fije%2Fdyh028">"Clinical trial of patulin in the common cold. 1944"</a>. <i>Int J Epidemiol</i>. <b>33</b> (2): 243–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fije%2Fdyh028">10.1093/ije/dyh028</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15082620">15082620</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int+J+Epidemiol&amp;rft.atitle=Clinical+trial+of+patulin+in+the+common+cold.+1944&amp;rft.volume=33&amp;rft.issue=2&amp;rft.pages=243-6&amp;rft.date=2004-04&amp;rft_id=info%3Adoi%2F10.1093%2Fije%2Fdyh028&amp;rft_id=info%3Apmid%2F15082620&amp;rft.au=Patulin+Clinical+Trials+Committee%2C+Medical+Research+Council&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Fije%252Fdyh028&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChalmersClarke2004" class="citation journal cs1">Chalmers I, Clarke M (April 2004). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fije%2Fdyh162">"Commentary: the 1944 patulin trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council"</a>. <i>Int J Epidemiol</i>. <b>33</b> (2): 253–60. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fije%2Fdyh162">10.1093/ije/dyh162</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15082623">15082623</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Int+J+Epidemiol&amp;rft.atitle=Commentary%3A+the+1944+patulin+trial%3A+the+first+properly+controlled+multicentre+trial+conducted+under+the+aegis+of+the+British+Medical+Research+Council&amp;rft.volume=33&amp;rft.issue=2&amp;rft.pages=253-60&amp;rft.date=2004-04&amp;rft_id=info%3Adoi%2F10.1093%2Fije%2Fdyh162&amp;rft_id=info%3Apmid%2F15082623&amp;rft.aulast=Chalmers&amp;rft.aufirst=I&amp;rft.au=Clarke%2C+M&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Fije%252Fdyh162&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHemminki_E2005" class="citation web cs1">Hemminki E (2005). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20080828040111/http://www.jameslindlibrary.org/trial_records/20th_Century/1940s/elvainio_et_al/elvainio_commentary.html">"Commentary on an early placebo controlled trial in Finland"</a>. The James Lind Library. Archived from <a rel="nofollow" class="external text" href="http://www.jameslindlibrary.org/trial_records/20th_Century/1940s/elvainio_et_al/elvainio_commentary.html">the original</a> on 2008-08-28.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Commentary+on+an+early+placebo+controlled+trial+in+Finland&amp;rft.pub=The+James+Lind+Library&amp;rft.date=2005&amp;rft.au=Hemminki+E&amp;rft_id=http%3A%2F%2Fwww.jameslindlibrary.org%2Ftrial_records%2F20th_Century%2F1940s%2Felvainio_et_al%2Felvainio_commentary.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation journal cs1"><a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1002/jclp.v61:7/issuetoc">"Journal of Clinical Psychology: Vol 61, No 7"</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fjclp.v61%3A7">10.1002/jclp.v61:7</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Journal+of+Clinical+Psychology%3A+Vol+61%2C+No+7&amp;rft_id=info%3Adoi%2F10.1002%2Fjclp.v61%3A7&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1002%2Fjclp.v61%3A7%2Fissuetoc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span> <span class="cs1-hidden-error citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_journal" title="Template:Cite journal">cite journal</a>}}</code>: </span><span class="cs1-hidden-error citation-comment">Cite journal requires <code class="cs1-code">&#124;journal=</code> (<a href="/wiki/Help:CS1_errors#missing_periodical" title="Help:CS1 errors">help</a>)</span></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHerbert_James_D2005" class="citation journal cs1">Herbert James D (2005). "Moving from empirically supported treatment lists to practice guidelines in psychotherapy: The role of the placebo concept". <i>Journal of Clinical Psychology</i>. <b>10</b> (7): 893–908. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fjclp.20133">10.1002/jclp.20133</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15827997">15827997</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Psychology&amp;rft.atitle=Moving+from+empirically+supported+treatment+lists+to+practice+guidelines+in+psychotherapy%3A+The+role+of+the+placebo+concept&amp;rft.volume=10&amp;rft.issue=7&amp;rft.pages=893-908&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1002%2Fjclp.20133&amp;rft_id=info%3Apmid%2F15827997&amp;rft.au=Herbert+James+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APlacebo-controlled+study" class="Z3988"></span></span>
</li>
</ol></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Placebo-controlled_study&amp;action=edit&amp;section=19" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000">
<tbody><tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/40px-Wiktionary-logo-en-v2.svg.png" decoding="async" width="40" height="40" class="noviewer" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/60px-Wiktionary-logo-en-v2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/99/Wiktionary-logo-en-v2.svg/80px-Wiktionary-logo-en-v2.svg.png 2x" data-file-width="512" data-file-height="512" /></td>
<td class="mbox-text plainlist">Look up <i><b><a href="https://en.wiktionary.org/wiki/placebo" class="extiw" title="wiktionary:placebo">placebo</a></b></i> in Wiktionary, the free dictionary.</td></tr>
</tbody></table>
<ul><li><a rel="nofollow" class="external text" href="https://web.archive.org/web/20090123201305/http://www.jameslindlibrary.org/index.html">James Lind Library</a> A source of historical texts on fair tests of treatments in health care.</li></ul>
<div class="navbox-styles nomobile"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role="navigation" class="navbox" aria-labelledby="Clinical_research_and_experimental_design" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Medical_research_studies" title="Template:Medical research studies"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Medical_research_studies" title="Template talk:Medical research studies"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Medical_research_studies&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Clinical_research_and_experimental_design" style="font-size:114%;margin:0 4em"><a href="/wiki/Clinical_research" title="Clinical research">Clinical research</a> and <a href="/wiki/Design_of_experiments" title="Design of experiments">experimental design</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Overview</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trial</a>
<ul><li><a href="/wiki/Protocol_(science)" title="Protocol (science)">Trial protocols</a></li>
<li><a href="/wiki/Adaptive_clinical_trial" title="Adaptive clinical trial">Adaptive clinical trial</a></li></ul></li>
<li><a href="/wiki/Academic_clinical_trials" class="mw-redirect" title="Academic clinical trials">Academic clinical trials</a></li>
<li><a href="/wiki/Clinical_study_design" title="Clinical study design">Clinical study design</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Scientific_control" title="Scientific control">Controlled study</a><br />(<a href="/wiki/Hierarchy_of_evidence#USA" title="Hierarchy of evidence">EBM I to II-1</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">Randomized controlled trial</a>
<ul><li><a href="/wiki/Experiment" title="Experiment">Scientific experiment</a></li>
<li><a href="/wiki/Blind_experiment" class="mw-redirect" title="Blind experiment">Blind experiment</a></li>
<li><a href="/wiki/Open-label_trial" title="Open-label trial">Open-label trial</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Observational_study" title="Observational study">Observational study</a><br />(<a href="/wiki/Hierarchy_of_evidence#USA" title="Hierarchy of evidence">EBM II-2 to II-3</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Cross-sectional_study" title="Cross-sectional study">Cross-sectional study</a> vs. <a href="/wiki/Longitudinal_study" title="Longitudinal study">Longitudinal study</a>, <a href="/wiki/Ecological_study" title="Ecological study">Ecological study</a></li>
<li><a href="/wiki/Cohort_study" title="Cohort study">Cohort study</a>
<ul><li><a href="/wiki/Retrospective_cohort_study" title="Retrospective cohort study">Retrospective</a></li>
<li><a href="/wiki/Prospective_cohort_study" title="Prospective cohort study">Prospective</a></li></ul></li>
<li><a href="/wiki/Case%E2%80%93control_study" title="Case–control study">Case–control study</a> (<a href="/wiki/Nested_case%E2%80%93control_study" title="Nested case–control study">Nested case–control study</a>)</li>
<li><a href="/wiki/Case_series" title="Case series">Case series</a></li>
<li><a href="/wiki/Case_study" title="Case study">Case study</a></li>
<li><a href="/wiki/Case_report" title="Case report">Case report</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Outcome_measure" title="Outcome measure">Measures</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epidemiological_methods#Measures_of_occurrence" class="mw-redirect" title="Epidemiological methods">Occurrence</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">Incidence</a>, <a href="/wiki/Cumulative_incidence" class="mw-redirect" title="Cumulative incidence">Cumulative incidence</a>, <a href="/wiki/Prevalence" title="Prevalence">Prevalence</a>, <a href="/wiki/Point_prevalence" class="mw-redirect" title="Point prevalence">Point prevalence</a>, <a href="/wiki/Period_prevalence" class="mw-redirect" title="Period prevalence">Period prevalence</a></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epidemiological_methods#Measures_of_association" class="mw-redirect" title="Epidemiological methods">Association</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><a href="/wiki/Risk_difference" title="Risk difference">Risk difference</a>, <a href="/wiki/Number_needed_to_treat" title="Number needed to treat">Number needed to treat</a>, <a href="/wiki/Number_needed_to_harm" title="Number needed to harm">Number needed to harm</a>, <a href="/wiki/Risk_ratio" class="mw-redirect" title="Risk ratio">Risk ratio</a>, <a href="/wiki/Relative_risk_reduction" title="Relative risk reduction">Relative risk reduction</a>, <a href="/wiki/Odds_ratio" title="Odds ratio">Odds ratio</a>, <a href="/wiki/Hazard_ratio" title="Hazard ratio">Hazard ratio</a></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Population_impact_measure" title="Population impact measure">Population impact</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><a href="/wiki/Attributable_fraction_among_the_exposed" title="Attributable fraction among the exposed">Attributable fraction among the exposed</a>, <a href="/wiki/Attributable_fraction_for_the_population" title="Attributable fraction for the population">Attributable fraction for the population</a>, <a href="/wiki/Preventable_fraction_among_the_unexposed" title="Preventable fraction among the unexposed">Preventable fraction among the unexposed</a>, <a href="/wiki/Preventable_fraction_for_the_population" title="Preventable fraction for the population">Preventable fraction for the population</a></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epidemiological_methods#Other_measures" class="mw-redirect" title="Epidemiological methods">Other</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><a href="/wiki/Clinical_endpoint" title="Clinical endpoint">Clinical endpoint</a>, <a href="/wiki/Virulence" title="Virulence">Virulence</a>, <a href="/wiki/Infectivity" title="Infectivity">Infectivity</a>, <a href="/wiki/Mortality_rate" title="Mortality rate">Mortality rate</a>, <a href="/wiki/Morbidity" class="mw-redirect" title="Morbidity">Morbidity</a>, <a href="/wiki/Case_fatality_rate" title="Case fatality rate">Case fatality rate</a>, <a href="/wiki/Specificity_and_sensitivity" class="mw-redirect" title="Specificity and sensitivity">Specificity and sensitivity</a>, <a href="/wiki/Likelihood_ratios_in_diagnostic_testing" title="Likelihood ratios in diagnostic testing">Likelihood-ratios</a>, <a href="/wiki/Pre-_and_post-test_probability" title="Pre- and post-test probability">Pre- and post-test probability</a></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Trial/test types</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/In_vitro" title="In vitro">In vitro</a></li>
<li><a href="/wiki/In_vivo" title="In vivo">In vivo</a></li>
<li><a href="/wiki/Animal_testing" title="Animal testing">Animal testing</a></li>
<li><a href="/wiki/Animal_testing_on_non-human_primates" title="Animal testing on non-human primates">Animal testing on non-human primates</a></li>
<li><a href="/wiki/First-in-man_study" class="mw-redirect" title="First-in-man study">First-in-man study</a></li>
<li><a href="/wiki/Multicenter_trial" title="Multicenter trial">Multicenter trial</a></li>
<li><a href="/wiki/Seeding_trial" title="Seeding trial">Seeding trial</a></li>
<li><a href="/wiki/Vaccine_trial" title="Vaccine trial">Vaccine trial</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Analysis_of_clinical_trials" title="Analysis of clinical trials">Analysis of clinical trials</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Risk%E2%80%93benefit_ratio" title="Risk–benefit ratio">Risk–benefit ratio</a></li>
<li><a href="/wiki/Systematic_review" title="Systematic review">Systematic review</a></li>
<li><a href="/wiki/Reproducibility" title="Reproducibility">Replication</a></li>
<li><a href="/wiki/Meta-analysis" title="Meta-analysis">Meta-analysis</a></li>
<li><a href="/wiki/Intention-to-treat_analysis" title="Intention-to-treat analysis">Intention-to-treat analysis</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Interpretation of results</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Selection_bias" title="Selection bias">Selection bias</a></li>
<li><a href="/wiki/Survivorship_bias" title="Survivorship bias">Survivorship bias</a></li>
<li><a href="/wiki/Correlation_does_not_imply_causation" title="Correlation does not imply causation">Correlation does not imply causation</a></li>
<li><a href="/wiki/Null_result" title="Null result">Null result</a></li>
<li><a href="/wiki/Sex_as_a_biological_variable" title="Sex as a biological variable">Sex as a biological variable</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><b><a href="/wiki/Category:Clinical_research" title="Category:Clinical research">Category</a></b></li>
<li><b><a href="/wiki/Glossary_of_clinical_research" title="Glossary of clinical research">Glossary</a></b></li>
<li><b><a href="/wiki/List_of_clinical_research_topics" class="mw-redirect" title="List of clinical research topics">List of topics</a></b></li></ul>
</div></td></tr></tbody></table></div></div>